What are the equivalent dosing ratios of furosemide, Bumex (bumetanide) and torsemide?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Equivalent Dosing of Furosemide, Bumetanide, and Torsemide

The equivalent dosing ratio of furosemide to bumetanide to torsemide is 40:1:10, meaning 40 mg of furosemide equals 1 mg of bumetanide equals 10 mg of torsemide. 1, 2, 3

Pharmacological Properties and Equivalence

  • Bumetanide is a potent loop diuretic with a diuretic potency approximately 40 times that of furosemide (1 mg bumetanide ≈ 40 mg furosemide) 2
  • Torsemide has a potency ratio of approximately 4:1 compared to furosemide (10 mg torsemide ≈ 40 mg furosemide) 3
  • All three medications work through the same mechanism: inhibition of the Na+/K+/2Cl- cotransport in the thick ascending limb of the loop of Henle 4

Pharmacokinetic Differences

Duration of Action

  • Bumetanide has a short duration of action (4-6 hours) and elimination half-life of 1-1.5 hours 1, 2
  • Furosemide has an intermediate duration of action with variable bioavailability 3
  • Torsemide has a longer elimination half-life (3-4 hours) compared to both bumetanide and furosemide 4, 5

Bioavailability

  • Bumetanide has high bioavailability (>80%) 2
  • Torsemide also has high bioavailability (>80%) 4, 5
  • Furosemide has more variable and generally lower bioavailability compared to the other two agents 3

Clinical Applications and Dosing Considerations

  • For initial treatment in acute heart failure, the recommended starting dose is 20-40 mg IV furosemide (or equivalent: 0.5-1 mg bumetanide or 10-20 mg torsemide) 6
  • For patients on chronic diuretic therapy, the initial IV dose should be at least equivalent to their oral dose 6
  • Maximum daily dose of bumetanide should not exceed 10 mg 1

Special Considerations

  • Despite theoretical pharmacokinetic advantages of torsemide over furosemide (longer half-life, better bioavailability), recent research shows no significant clinical outcome differences between the two medications 3
  • When higher doses of torsemide are used (compared to equivalent furosemide doses), greater neurohormonal activation and kidney dysfunction may occur, offsetting the natriuretic benefits 3
  • Bumetanide may show a more dose-dependent diuretic effect in patients recovering from acute renal failure 7

Common Pitfalls and Caveats

  • Clinicians often use a 2:1 dose equivalence conversion between furosemide and torsemide, but research suggests a 4:1 ratio results in similar natriuresis 3
  • When switching between diuretics, careful monitoring of electrolytes, renal function, and clinical response is essential 1
  • All loop diuretics can cause similar adverse effects including electrolyte disturbances (particularly hypokalemia), hyperuricemia, and activation of the renin-angiotensin-aldosterone system 4, 8
  • Combination therapy with thiazide diuretics may be considered in cases of diuretic resistance rather than exceeding maximum recommended doses of loop diuretics 6, 1

References

Guideline

Bumetanide Administration and Dosage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mechanistic Differences between Torsemide and Furosemide.

Journal of the American Society of Nephrology : JASN, 2025

Research

Torsemide: a pyridine-sulfonylurea loop diuretic.

The Annals of pharmacotherapy, 1995

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Torsemide as a Primary Choice in Edema Associated with Heart Failure.

The Journal of the Association of Physicians of India, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.